Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013 (2013), Article ID 369609, 9 pages
Research Article

Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer

1Institute for Biological Interfaces of Engineering, Clemson University, Clemson, SC 29634, USA
2Department of Bioengineering, Clemson University, Clemson, SC 29634, USA

Received 17 July 2013; Revised 26 September 2013; Accepted 27 September 2013

Academic Editor: Claudio Luparello

Copyright © 2013 Brian W. Booth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Bonglee Kim, Sanjay K Srivastava, and Sung-Hoon Kim, “Caspase-9 as a therapeutic target for treating cancer,” Expert Opinion on Therapeutic Targets, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Fangyuan Nie, Yan Liang, Bing Jiang, Xiabing Li, Hang Xun, Wei He, Hay Tong Lau, and Xiaofeng Ma, “Apoptotic effect of tannic acid on fatty acid synthase over-expressed human breast cancer cells,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Nadiya Druzhyna, Bartosz Szczesny, Gabor Olah, Katalin Módis, Antonia Asimakopoulou, Athanasia Pavlidou, Petra Szoleczky, Domokos Gerö, Kazunori Yanagi, Gabor Törö, Isabel López-García, Vassilios Myrianthopoulos, Emmanuel Mikros, John R. Zatarain, Celia Chao, Andreas Papapetropoulos, Mark R. Hellmich, and Csaba Szabo, “Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer,” Pharmacological Research, 2016. View at Publisher · View at Google Scholar
  • J. R. Aguilera, V. Venegas, J. M. Oliva, M. J. Sayagués, M. de Miguel, J. A. Sánchez-Alcázar, M. Arévalo-Rodríguez, and A. P. Zaderenko, “Targeted multifunctional tannic acid nanoparticles,” RSC Adv., vol. 6, no. 9, pp. 7279–7287, 2016. View at Publisher · View at Google Scholar
  • Lauren G. Jordan, and Brian W. Booth, “ HER2 + breast cancer cells undergo apoptosis upon exposure to tannic acid released from remodeled cross-linked collagen type I ,” Journal of Biomedical Materials Research Part A, 2017. View at Publisher · View at Google Scholar
  • Anil Khushalrao Shendge, Tapasree Basu, Dipankar Chaudhuri, Sourav Panja, and Nripendranath Mandal, “In vitro Antioxidant and Antiproliferative Activities of Various Solvent Fractions from Clerodendrum viscosum Leaves.,” Pharmacognosy magazine, vol. 13, no. Suppl2, 2017. View at Publisher · View at Google Scholar
  • Li-Mei Yue, Jinhyuk Lee, Li Zheng, Yong-Doo Park, Zhuo-Ming Ye, and Jun-Mo Yang, “Computational prediction integrating the inhibition kinetics of gallotannin on α-glucosidase,” International Journal of Biological Macromolecules, 2017. View at Publisher · View at Google Scholar
  • Luís Gomes, Carlos Borges, M Luísa M Serralheiro, Miguel Minhalma, and Rita Pacheco, “Cork processing wastewaters components fractioned by ultrafiltration membranes - studies of antioxidant and antitumoral activity,” Journal of Chemical Technology & Biotechnology, 2017. View at Publisher · View at Google Scholar
  • Christopher J. Bridgeman, Thuy-Uyen Nguyen, and Vipuil Kishore, “Anticancer efficacy of tannic acid is dependent on the stiffness of the underlying matrix,” Journal of Biomaterials Science, Polymer Edition, pp. 1–16, 2018. View at Publisher · View at Google Scholar